Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Lower SHBG levels may increase the risk of PCOS.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Despite progress, better treatments and understanding are needed for the high rates of long-term issues and deaths linked to eating disorders.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Some breast cancer chemotherapy can cause permanent hair loss.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Neurosteroids show promise for treating epilepsy and more research is needed.

Researchers found 63 genes linked to male-pattern baldness, which could help in understanding its biology and developing new treatments.

Zinc can both inhibit and stimulate mouse hair growth, and might help recover hair after chemotherapy.

Finasteride may help treat chronic CSC, improving vision.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

All three treatments reduce hirsutism, but spironolactone works best long-term.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.